Literature DB >> 15620411

The orexinergic synaptic innervation of serotonin- and orexin 1-receptor-containing neurons in the dorsal raphe nucleus.

Qing-Ping Wang1, Yoshimasa Koyama, Jian-Lian Guan, Kazumi Takahashi, Yukihiko Kayama, Seiji Shioda.   

Abstract

Orexin/hypocretin has been well demonstrated to excite the serotonergic neurons in the dorsal raphe nucleus (DRN). We studied the morphological relationships between orexin-containing axon terminals and serotonin- as well as orexin-receptor-containing neurons in the dorsal raphe nucleus. Using immunohistochemical techniques at the light microscopic level, orexin A (OXA)-like immunoreactive neuronal fibers in the DRN were found to make close contact with serotonergic neurons, while some of the serotonergic neurons also expressed the orexin 1 receptor (OX1R). At the electron microscopic level, double-immunostaining experiments showed that the orexin A-like immunoreactive fibers were present mostly as axon terminals that made synapses on the serotonin- and orexin 1-receptor-containing neurons. While only axodendritic synapses between orexin A-containing axon terminals and serotonergic neurons were detected, the synapses made by orexin A-containing axon terminals on the orexin 1-receptor-containing neurons were both axodendritic and axosomatic. The present study suggests that excitation effect of orexin A on dorsal raphe serotonergic neurons is via synaptic communication through orexin 1 receptor.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15620411     DOI: 10.1016/j.regpep.2004.08.030

Source DB:  PubMed          Journal:  Regul Pept        ISSN: 0167-0115


  10 in total

Review 1.  Role of orexin in central regulation of gastrointestinal functions.

Authors:  Toshikatsu Okumura; Kaoru Takakusaki
Journal:  J Gastroenterol       Date:  2008-09-20       Impact factor: 7.527

Review 2.  The Deakin/Graeff hypothesis: focus on serotonergic inhibition of panic.

Authors:  Evan D Paul; Philip L Johnson; Anantha Shekhar; Christopher A Lowry
Journal:  Neurosci Biobehav Rev       Date:  2014-03-21       Impact factor: 8.989

3.  Modulation of Noradrenergic and Serotonergic Systems by Cannabinoids: Electrophysiological, Neurochemical and Behavioral Evidence.

Authors:  Aitziber Mendiguren; Erik Aostri; Joseba Pineda
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 4.  Serotonin neuron development: shaping molecular and structural identities.

Authors:  Evan Deneris; Patricia Gaspar
Journal:  Wiley Interdiscip Rev Dev Biol       Date:  2017-10-26       Impact factor: 5.814

5.  Serotonin and the regulation of mammalian energy balance.

Authors:  Michael H Donovan; Laurence H Tecott
Journal:  Front Neurosci       Date:  2013-03-27       Impact factor: 4.677

6.  Early expression of hypocretin/orexin in the chick embryo brain.

Authors:  Kyle E Godden; Jeremy P Landry; Natalya Slepneva; Paola V Migues; Maria Pompeiano
Journal:  PLoS One       Date:  2014-09-04       Impact factor: 3.240

Review 7.  Physiological Role of Orexinergic System for Health.

Authors:  Ines Villano; Marco La Marra; Girolamo Di Maio; Vincenzo Monda; Sergio Chieffi; Ezia Guatteo; Giovanni Messina; Fiorenzo Moscatelli; Marcellino Monda; Antonietta Messina
Journal:  Int J Environ Res Public Health       Date:  2022-07-08       Impact factor: 4.614

8.  Hypothalamic orexinergic neuron changes during the hibernation of the Syrian hamster.

Authors:  Jesús M López; Paula Carballeira; Javier Pozo; Gonzalo León-Espinosa; Alberto Muñoz
Journal:  Front Neuroanat       Date:  2022-09-09       Impact factor: 3.543

9.  Differential roles of orexin receptors in the regulation of sleep/wakefulness.

Authors:  Michihiro Mieda; Natsuko Tsujino; Takeshi Sakurai
Journal:  Front Endocrinol (Lausanne)       Date:  2013-05-16       Impact factor: 5.555

10.  Hypocretin1/orexinA-immunoreactive axons form few synaptic contacts on rat ventral tegmental area neurons that project to the medial prefrontal cortex.

Authors:  Esther Del Cid-Pellitero; Miguel Garzón
Journal:  BMC Neurosci       Date:  2014-09-07       Impact factor: 3.288

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.